Graham Corporation, a global leader in mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries, has announced plans to build an advanced cryogenic propellant testing facility in Florida, near its P3 Technologies, LLC subsidiary. This facility leverages Graham’s expertise in cryogenic and space launch technology to meet growing demand for efficient, scalable testing solutions across key sectors such as space, defense, and new energy, with potential applications in the medical field.
The facility will provide a cost-effective, timely alternative to current testing centers, which often prioritize flagship programs, leaving fewer options for other critical projects. Equipped to test liquid hydrogen (LH2), liquid oxygen (LOX), and liquid methane (LCH4) at pressurized, sub-cooled, or saturated conditions, the facility will be ideal for testing pumps, components, fluid management systems, and combustion devices. This expansion of Graham’s cryogenic propellant testing capabilities aims to offer enhanced support for current and future customer programs, adding agility and depth to meet evolving requirements.
“This new testing facility strengthens our role as a trusted partner by addressing customer needs for timely and cost-effective cryogenic propellant testing,” said Dan Thoren, Graham Corporation President and CEO. “This investment underscores our commitment to advancing support for current and future customer programs through innovative, accessible testing solutions while enhancing our presence in the space, defense, and new energy sectors.”
The project is expected to be completed over the next year, with initial tests projected to begin by mid-2025. Graham anticipates a cash payback period of two to three years and an internal rate of return exceeding 20%, marking a strategic investment in the company’s future.
